Loading
A phase 3 trial of Pilocarpine in Breast cancer, run by Alliance for Clinical Trials in Oncology, completed.
Pilocarpine in Treating Vaginal Dryness in Patients With Breast Cancer is a phase 3 interventional study registered as NCT00343382 by Alliance for Clinical Trials in Oncology, with 201 participants recorded, started 2006-12 and reaching its primary completion in 2009-07. Interventions recorded: pilocarpine hydrochloride, placebo. Conditions recorded: Breast Cancer, Vaginal Dryness.
Linked to the drug Pilocarpine because the registry names it among its interventions and Breast cancer among its conditions. Registry record only: no result has been read by an editor.
Numbers are from the trial as recorded here; see the source links in the table below. This is orientation, not medical advice: ask your team how closely the trial population matches you.
201 enrolled.
SD 24.04; Figures from the ClinicalTrials.gov results section (first posted 2014-09-30), not from a publication · SD 27.69 · SD 21.38
Source| Endpoint | Arm | n | Value | HR (95% CI) | p | Source |
|---|---|---|---|---|---|---|
| Average Vaginal Dryness Scores Via Area Under the Curve (AUC) Summary Statisticsprimary | Collective Placebo | 61 | 63.6 units on a scale | - | - | link |
| Pilocarpine 2 Times Per Day | 61 | 55.8 units on a scale | ||||
| Pilocarpine 4 Times Per Day | 55 | 66 units on a scale |
Shares Pilocarpine and the tag pipeline.
Shares Alliance for Clinical Trials in Oncology, Breast cancer (all types) and the tag pipeline.
Shares Pilocarpine and the tag pipeline.
Shares Alliance for Clinical Trials in Oncology, Breast cancer (all types) and the tag pipeline.
Shares Alliance for Clinical Trials in Oncology and the tag pipeline.
Shares Breast cancer (all types) and the tag pipeline.
Shares Breast cancer (all types) and the tag pipeline.
Shares Breast cancer (all types) and the tag pipeline.